Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the objective response rate and safety in
platinum-resistant epithelial ovarian/fallopian tube/primary peritoneal cancer patients
treated with vinorelbine and gemcitabine combination chemotherapy.